When the average tumor volume approached 100 mm3, the treatment group received doses of 10 mg/kg, 5 mg/kg, and 2.5 mg/kg of Nectin-4 NDC (Fig. 6A). The gene discussed is NECTIN4; the disease is neoplasm.